Zacks.com on MSN22d
QIAGEN Stock Likely to Gain on Collaboration for APOE GenotypingAdditionally, QIAGEN has 14 FDA-approved PCR-based companion diagnostics for disease areas, including cancer and Parkinson’s.
Genotyping methods used for detection of mixed-genotype human cytomegalovirus infections. Degenerate and LNA-substituted PCR assays Not determined Increases the likelihood of discovering novel ...
Zacks.com on MSN8d
QGEN Stock Likely to Gain From Newly Launched Assays for QIAcuityQIAGEN N.V. QGEN recently announced the launch of 100 new assays for its digital polymerase chain reaction (dPCR) platform — ...
The Genomics Core Laboratory has the capability of performing standard fluorescent and Next-Generation Sequencing (NGS), high and low throughput custom genotyping from 1 SNP to more than 5 million ...
Reporter and Recombinase KI alleles: With information from the investigator describing the location of the desired KI, the core will select guide RNAs, design a suitable repair template to insert the ...
The following is a summary of “Population-based age- and type-specific prevalence of human papillomavirus among non-vaccinated women aged 30 years and above in Germany,” published in the September ...
will now develop new genotyping assays based on Qiagen’s QIAstat‑Dx multiplex PCR system. Their goal is to offer a quick companion diagnostic that could be turned around while a patient is ...
Dual 96-well and dual 384-well blocks are available for your high-throughput PCR sequencing needs, and a dual flat block is available to support Applied Biosystems OpenArray plate technology for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback